JAMAL F ALI
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology HAGERSTOWN, MD NPI 1528028230
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MD Alexion Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$9,194.74
- Category: General Payments
- Program years: PY2018–2024
- Record count: 515
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,282.59 across 56 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,074.77 | 52 |
| Education | $207.82 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $196.72 | 5 |
| ABBVIE INC. | $154.93 | 11 |
| SK Life Science, Inc. | $137.51 | 3 |
| Lilly USA, LLC | $135.17 | 6 |
| EMD Serono, Inc. | $97.07 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $87.41 | 4 |
| Teva Pharmaceuticals USA, Inc. | $58.21 | 3 |
| Kyowa Kirin, Inc. | $51.54 | 2 |
| Biogen, Inc. | $44.95 | 2 |
| ANI Pharmaceuticals, Inc. | $44.80 | 2 |
| ARGENX US, INC. | $36.17 | 2 |
| Lundbeck LLC | $34.41 | 2 |
| Currax Pharmaceuticals LLC | $27.96 | 2 |
| Nevro Corp. | $26.11 | 1 |
| Alnylam Pharmaceuticals Inc. | $24.57 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $23.98 | 1 |
| UCB, Inc. | $19.16 | 1 |
| Merz Pharmaceuticals, LLC | $18.31 | 1 |
| Amneal Pharmaceuticals LLC | $17.40 | 1 |
| Neurelis, Inc. | $16.15 | 1 |
| PFIZER INC. | $15.80 | 1 |
| Sumitomo Pharma America, Inc. | $14.26 | 1 |
By program year
Records — PY2024 (56)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.